ImmuneOnco Biopharmaceuticals (Shanghai) Inc

NEW
FRA:R9Z (China)   Ordinary Shares - Class H
€ 0.38 +0.038 (+11.52%) Aug 12
At Loss
P/B:
1.81
Market Cap:
€ 165.97M ($ 191.25M)
Enterprise V:
€ 64.67M ($ 74.52M)
Volume:
0
Avg Vol (2M):
0
Trade In:

This is a preview!

Analysis and historical valuations for Apple Inc are shown here for you to look at this page's features.

AAPL Stock Intrinsic Values - Apple Inc